Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) EPS (Basic) (2016 - 2026)

Ekso Bionics Holdings has reported EPS (Basic) over the past 14 years, most recently at -$1.56 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 24.27% to -$1.56 in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.46, a 40.14% increase, with the full-year FY2025 number at -$4.91, up 41.76% from a year prior.
  • EPS (Basic) reached -$1.56 in Q4 2025 per EKSO's latest filing, down from -$0.54 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.1 in Q2 2021, with the low at -$2.06 in Q4 2024.
  • The 5-year median for EPS (Basic) is -$0.32 (2022), against an average of -$0.62.
  • Peak YoY movement for EPS (Basic): skyrocketed 94.68% in 2021, then crashed 836.36% in 2024.
  • Tracing EKSO's EPS (Basic) over 5 years: stood at -$0.23 in 2021, then fell by 4.35% to -$0.24 in 2022, then rose by 8.33% to -$0.22 in 2023, then crashed by 836.36% to -$2.06 in 2024, then grew by 24.27% to -$1.56 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$1.56, -$0.54, and -$1.24 for Q4 2025, Q3 2025, and Q2 2025 respectively.